Although citrus fruits prevent and cure scurvy, they may not always be as good for you as you thought.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Tröhler, U. in To improve the evidence of medicine: The 18th century British origins of a critical approach. (Royal College of Physicians of Edinburgh, Edinburgh) 68–81 (United Kingdom, 2000).
Carr, A.C. & Frei, B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am. J. Clin. Nutr. 69, 1086–1107 (1999).
National Research Council in Recommended dietary allowances. 10th edn (National Academic Press, Washington DC, 1989).
Levine, M. et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA 93, 3704–3709 (1996).
Stewart, M.L., McDonald, J.T., Levy, A.S., Schucker, R.E. & Henderson, D.P. Vitamin/mineral supplement use: a telephone survey of adults in the United States. J. Am. Diet. Assoc. 85, 1585–1590 (1985).
Gershoff, S.N. Vitamin C (ascorbic acid): new roles, new requirements? Nutr. Rev. 51, 313–326 (1993).
Douglas, R.M., Chalker, E.B. & Treacy, B. Vitamin C for preventing and treating the common cold (Cochrane review) in The Cochrane Library. Update Software, Issue 3 (Oxford, UK, 2000).
Evans, J.R. & Henshaw, K. Antioxidant vitamin and mineral supplementation for preventing age-related macular degeneration (Cochrane review) in The Cochrane Library. Update Software, Issue 3 (Oxford, UK, 2000).
Kaur, B. Vitamin C supplementation asthma (protocol for a Cochrane review) in The Cochrane Library. Update Software, Issue 3 (Oxford, UK, 2000).
Blanchard, J., Tozer, T.N. & Rowland, M. Pharmacokinetic perspectives on megadoses of ascorbic acid. Am. J. Clin. Nutr. 66, 1165–1171 (1997).
Basu, T.K. & Schorah, C.J. in Vitamin C in health and disease. (The Avi Publishing Company, Westport, Connecticut, 1982). 61–63.
Meyers, D.G., Maloley, P.A. & Weeks, D. Safety of antioxidant vitamins. Arch. Intern. Med. 156, 925–935 (1996).
Auer, B.L., Auer, D. & Rodgers, A.L. The effect of ascorbic acid ingestion on the biochemical and physicochemical risk factors associated with calcium oxalate kidney stone formation. Clin. Chem. Lab. Med. 36, 143–147 (1998).
Barness, L.A. Safety considerations with high ascorbic acid dosage. Ann. NY Acad. Sci. 258, 523–528 (1975).
Dresser, G.K., Spence, J.D. & Bailey, D.G. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome p450 3A4 inhibition. Clin. Pharmacokinet. 38, 41–57 (2000).
Anonymous. Grapefruit warning label: now official in some countries. Drugs Ther. Perspect. 12, 12–13 (1998).
Committee on Safety of Medicines, Medicines Control Agency. Terfenadine: now only available on prescription. Curr. Probl. Pharmacovig. 23, 9 (1997).
Committee on Safety of Medicines, Medicines Control Agency. Astemizole (Hismanal): only available on prescription. Curr. Probl. Pharmacovig. 25, 2 (1999).
Bailey, D.G., Spence, J.D., Edgar, B., Bayliff, C.D. & Arnold, J.M. Ethanol enhances the hemodynamic effects of felodipine. Clin. Invest. Med. 12, 357–362 (1989).
Dresser, G.K., Bailey, D.G. & Carruthers, S.G. Grapefruit juice–felodipine interaction in the elderly. Clin. Pharmacol. Ther. 68, 28–34 (2000).
Dresser, G.K., Spence, J.D. & Bailey, D.G. Pharmacokinetic–pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin. Pharmacokinet. 38, 41–57 (2000).
Bailey, D.G., Malcolm, J., Arnold, O. & Spence, J.D. Grapefruit juice–drug interactions. Br. J. Clin. Pharmacol. 46, 101–110 (1998).
Eagling, V.A., Profit, L. & Back, D.J. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br. J. Clin. Pharmacol. 48, 543–552 (1999).
Guo, L.Q., Fukuda, K., Ohta, T. & Yamazoe, Y. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab. Dispos. 28, 766–771 (2000).
Ranganna, S., Govindarajan, V.S. & Ramana, K.V. Citrus fruits—varieties, chemistry, technology, and quality evaluation. Part II. Chemistry, technology, and quality evaluation. Crit. Rev. Food. Sci. Nutr. 18, 313–386 (1983).
Ranganna, S., Govindarajan, V.S. & Ramana, K.V. Citrus fruits. Part II. Chemistry, technology, and quality evaluation. B. Technology. Crit. Rev. Food Sci. Nutr. 19, 1–98 (1983).
Shaw, P.E., Moshonas, M.G., Hearn, C.J. & Goodner, K.L. Volatile constituents in fresh and processed juices from grapefruit and new grapefruit hybrids. J. Agric. Food Chem. 48, 2425–2429 (2000).
Ohnishi, A. et al. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. Br. J. Pharmacol. 130, 1369–1377 (2000).
About this article
Cite this article
Aronson, J. Forbidden fruit. Nat Med 7, 29–30 (2001). https://doi.org/10.1038/83312